Molecular profiling of melanoma and the evolution of patient-specific therapy.

Abstract excerpt

It recently has become clear that multiple molecular subtypes of melanoma likely exist that may be associated with clinical response to defined therapeutic modalities. Gene expression profiling has revealed a signature that is associated with clinical benefit to melanoma vaccines, with preliminary work suggesting a correlation with response to other immunotherapy agents as well. Activating mutations in B-Raf and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Vaccines
• Share to CAR-T cell therapy research
• Share to Gene Expression Profiling